Navigation Links
American Society for Microbiology honors Stephen C. Edberg
Date:7/16/2008

Washington, DCMay 28, 2008The 2008 American Society for Microbiology (ASM) BD Award for Research in Clinical Microbiology is being presented to Stephen C. Edberg, Professor, Department of Laboratory Medicine and Internal Medicine, Yale University School of Medicine, and Director, Clinical Microbiology Laboratory, Yale-New Haven Hospital. Sponsored by BD Diagnostic Systems, this award recognizes a distinguished scientist for research accomplishments that form the foundation for important applications in clinical microbiology.

Dr. Edberg's contributions to clinical microbiology are vast and have played a role in many public health issues. His research has resulted in more than 180 publications, and his work has been foundational in many areas. Among Dr. Edberg's research activities that have found their way into usage in clinical microbiology laboratories are: constitutive enzyme testing for the rapid identification of Gram-negative species, the refinement of immunoglobulin coating of latex particles for the direct detection of antigens, and the use of hydrolysable substrates to directly identify bacterial and mycotic isolates within one hour. His work laid the groundwork for many of today's rapid identification methods. Dr. Edberg's most significant contribution to global well-being was his development of the "Colilert" test for the detection and enumeration of Escherichia coli in drinking water under field and laboratory conditions. This test system is a monumental contribution to world health, especially in developing countries.

Dr. Edberg received his B.A. in Biology from Lehigh University, Bethlehem, Pennsylvania, and his M.A. in Bacteriology from Hofstra University, Hempstead, New York. He earned his Ph.D. at the State University of New York at Buffalo Medical School.

The BD Award for Research in Clinical Microbiology will be presented during the 108th General Meeting of the American Society for Microbiology (ASM), June 1 June 5, 2008 in Boston, Massachusetts. ASM is the world's oldest and largest life science organization and has more than 43,000 members worldwide. ASM's mission is to advance the microbiological sciences and promote the use of scientific knowledge for improved health and economic and environmental well-being.


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. American Society for Microbiology honors Steven A. Rosenberg
2. American Society for Microbiology honors Vickie S. Baselski
3. American Society for Microbiology honors Mary Ann Moran
4. American Society for Microbiology honors Regina S. Van Brakle
5. American Society for Microbiology honors Marvin Whiteley
6. American Society for Microbiology honors Jo Handelsman
7. American Society for Microbiology honors Dianne K. Newman
8. American Society for Microbiology honors Edward F. DeLong
9. American Society for Microbiology honors Anne M. Vidaver
10. American Society for Microbiology honors Arturo Casadevall
11. American Society for Microbiology honors Bala Swaminathan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/2/2016)... 2, 2016 Perimeter Surveillance & ... Systems, Physical Infrastructure, Support & Other Service  ... offers comprehensive analysis of the global Border ... generate revenues of $17.98 billion in 2016. ... a leader in software and hardware technologies for advanced ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: